
Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was […]